Results 251 to 260 of about 118,363 (290)
Some of the next articles are maybe not open access.

SEROTONERGIC SYSTEMS

Psychiatric Clinics of North America, 1997
Since its identification in neurons of the central nervous systems (CNS), serotonin (5-HT) has been implicated in the pathophysiology of psychiatric disorders, such as schizophrenia, depression, generalized anxiety disorder (GAD), panic disorder (PD), and obsessive-compulsive disorder (OCD).
openaire   +2 more sources

Deaths involving serotonergic drugs

Forensic Science International, 2010
Serotonin-active drugs are detected relatively frequently in Victorian deaths. During 2002-2008, there were 1123 fatalities where one or more of the serotonin-active drugs tramadol, venlafaxine, fluoxetine, sertraline, citalopram, paroxetine and MDMA, were detected. These deaths were reviewed using pathology, toxicology and police reports, to determine
J L, Pilgrim   +2 more
openaire   +2 more sources

Serotonergic modulation of Yawning

Pharmacology Biochemistry and Behavior, 1979
Yawning induced by intraperitoneal (IP) injection of physostigmine (0.15 mgKg-1), in infant or adult rats is potentiated by Lu 10-171 (0.5-10 mgKg-1), a selective serotonin uptake inhibiting drug, which, by itself does not induce yawning. This effect is counteracted by metergoline (5-10 mgKg-1, IP) which blocks serotonin postsynaptic receptors.
R, Urba-Holmgren   +3 more
openaire   +2 more sources

Serotonergic hypothesis of sleepwalking

Medical Hypotheses, 2005
Despite widespread prevalence of sleepwalking, its etiology and pathophysiology are not well understood. However, there is some evidence that sleepwalking can be precipitated by sleep-disordered breathing. A hypothesis is proposed that serotonergic system may be a link between sleep-disordered breathing and sleepwalking. Serotonergic neurons meet basic
Grzegorz R, Juszczak, Artur H, Swiergiel
openaire   +2 more sources

Serotonergic targets in depression

Current Opinion in Pharmacology, 2002
Serotonin reuptake inhibitors have proved to be a very effective treatment for depression and have strengthened the hypothesis that impaired 5-hydroxytryptamine (5-HT) neurotransmission may contribute to the underlying cause of depressive disorders. Extensive research has been carried out to investigate other 5-HT targets associated with the disease ...
Derek N, Middlemiss   +2 more
openaire   +2 more sources

Serotonergic mechanisms in anxiety

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1994
1. Anatomical, behavioral, neurochemical and electrophysiological evidence collectively support a role for central 5-HT in the modulation of anxiety and the anti-anxiety action of the benzodiazepines. 2. The advent of selective agonists and antagonists for 5-HT receptor subtypes (5-HT1, 5-HT2, 5-HT3) has rekindled investigation of the role of 5-HT in ...
A S, Eison, M S, Eison
openaire   +2 more sources

Novel serotonergic and non-serotonergic migraine headache therapies

Expert Opinion on Therapeutic Patents, 2001
In the last four years discovery of pharmacotherapeutic treatments for migraine headaches has received much attention. Since the patent literature was last reviewed in 1997 [1], advances have been made in the understanding of mechanism and pathophysiology of migraine. Introduction of sumatriptan to the market has led to acceleration in research efforts
Abdelmalik Slassi   +2 more
openaire   +1 more source

Serotonergic Genes and Suicidality

Crisis, 2001
Summary: Several lines of evidence indicate that abnormalities in the functioning of the central serotonergic system are involved in the pathogenesis of depressive illness and suicidal behavior. Studies have shown that the number of brain and platelet serotonin transporter binding sites are reduced in patients with depression and in suicide victims ...
L, Du   +4 more
openaire   +2 more sources

Serotonergic Functions in Man

2015
Abundant preclinical evidence suggests that serotonin-containing neural systems may participate in the regulation of both extrapyramidal and neuroendocrine function. In an attempt to examine these possibilities in man, patients with various neurologic disorders received drugs believed to facilitate or inhibit serotonergic function. Extrapyramidal signs
T N, Chase, I, Shoulson, A C, Carter
openaire   +2 more sources

Serotonergic mechanisms in hypertension

International Journal of Cardiology, 1993
Serotonin and abnormal serotonergic activity (both central and peripheral) may play a role in pathogenesis of essential hypertension. Serotonin acts chiefly via three types of receptors namely S1, S2 and S3 serotonergic receptors. Besides being vasoactive, it has some inotropic and chronotropic properties and also affects blood rheology.
M, Chandra, N, Chandra
openaire   +2 more sources

Home - About - Disclaimer - Privacy